BRCA2 Mutations Linked to Poor Treatment Response, Outcomes in Prostate Cancer

Jul

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients.

Jul

Featured Webinar

Single-Cell Sequencing Reveals Clonal Heterogeneity in Acute Lymphoblastic Leukemia

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.

Menu

BRCA2 Mutations Linked to Poor Treatment Response, Outcomes in Prostate Cancer

To read the full story....

Breaking News

Japan's National Cancer Center Adopts Qiagen Bioinformatics Platform for Precision Med Program

Roche's Rozlytrek Nets Japanese Approval in NTRK-Positive Pan Cancer Indication

European Commission Approves Lynparza for Advanced Ovarian Cancer With BRCA Mutations

FDA Approves Expanded Use of Agilent CDx for Keytruda in Head and Neck Cancer

Multi-Gene Panel Testing Finds Pathogenic Variant Carriers Missed Under Current Testing Guidelines

Saga Diagnostics Raises $4.2M

Featured White Papers

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

Single-Cell Sequencing Reveals Clonal Heterogeneity in Acute Lymphoblastic Leukemia

What's Popular?

Next-Generation Sequencing of Pediatric Cancer Patients Could Transform Treatment Paradigms

Wake Forest Researchers Learn From Patient Data in Offering Precision Oncology Broadly

ASCO Data Pushes Boundaries for Genomic Testing in Localized Breast Cancer

Japan's National Cancer Center Adopts Qiagen Bioinformatics Platform for Precision Med Program

Roche's Rozlytrek Nets Japanese Approval in NTRK-Positive Pan Cancer Indication

Sponsorships